nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—HTR1B—hypertension	0.268	1	CbGaD
Naratriptan—HTR1B—Pindolol—hypertension	0.0691	0.179	CbGbCtD
Naratriptan—HTR1B—Penbutolol—hypertension	0.0563	0.146	CbGbCtD
Naratriptan—HTR1A—Nebivolol—hypertension	0.0509	0.132	CbGbCtD
Naratriptan—HTR1D—Prazosin—hypertension	0.0464	0.12	CbGbCtD
Naratriptan—HTR1A—Pindolol—hypertension	0.0433	0.112	CbGbCtD
Naratriptan—HTR1B—Propranolol—hypertension	0.0354	0.0914	CbGbCtD
Naratriptan—HTR1A—Penbutolol—hypertension	0.0353	0.0912	CbGbCtD
Naratriptan—HTR1A—Prazosin—hypertension	0.0279	0.0721	CbGbCtD
Naratriptan—HTR1A—Propranolol—hypertension	0.0222	0.0573	CbGbCtD
Naratriptan—MAOA—locus ceruleus—hypertension	0.00386	0.173	CbGeAlD
Naratriptan—HTR1B—artery—hypertension	0.00158	0.0707	CbGeAlD
Naratriptan—HTR1D—artery—hypertension	0.00153	0.0684	CbGeAlD
Naratriptan—HTR1B—blood vessel—hypertension	0.00123	0.055	CbGeAlD
Naratriptan—HTR1D—blood vessel—hypertension	0.00119	0.0533	CbGeAlD
Naratriptan—HTR1F—central nervous system—hypertension	0.000826	0.037	CbGeAlD
Naratriptan—HTR1B—brainstem—hypertension	0.000671	0.0301	CbGeAlD
Naratriptan—MAOA—cardiac ventricle—hypertension	0.000652	0.0292	CbGeAlD
Naratriptan—HTR1D—brainstem—hypertension	0.00065	0.0291	CbGeAlD
Naratriptan—Eletriptan—HTR2B—hypertension	0.000614	0.215	CrCbGaD
Naratriptan—MAOA—myocardium—hypertension	0.000613	0.0275	CbGeAlD
Naratriptan—HTR1B—cardiovascular system—hypertension	0.000548	0.0246	CbGeAlD
Naratriptan—HTR1A—brainstem—hypertension	0.000542	0.0243	CbGeAlD
Naratriptan—HTR1D—cardiovascular system—hypertension	0.00053	0.0238	CbGeAlD
Naratriptan—HTR1D—kidney—hypertension	0.000519	0.0233	CbGeAlD
Naratriptan—MAOA—brainstem—hypertension	0.000495	0.0222	CbGeAlD
Naratriptan—Almotriptan—HTR1B—hypertension	0.000472	0.166	CrCbGaD
Naratriptan—Sumatriptan—HTR1B—hypertension	0.000455	0.159	CrCbGaD
Naratriptan—MAOA—nephron tubule—hypertension	0.00045	0.0202	CbGeAlD
Naratriptan—MAOA—adrenal cortex—hypertension	0.000443	0.0198	CbGeAlD
Naratriptan—HTR1A—cardiovascular system—hypertension	0.000442	0.0198	CbGeAlD
Naratriptan—MAOA—heart—hypertension	0.000428	0.0192	CbGeAlD
Naratriptan—MAOA—decidua—hypertension	0.000416	0.0187	CbGeAlD
Naratriptan—MAOA—cardiovascular system—hypertension	0.000404	0.0181	CbGeAlD
Naratriptan—MAOA—kidney—hypertension	0.000395	0.0177	CbGeAlD
Naratriptan—MAOA—cortex of kidney—hypertension	0.000385	0.0173	CbGeAlD
Naratriptan—Eletriptan—HTR7—hypertension	0.00038	0.133	CrCbGaD
Naratriptan—HTR1B—endocrine gland—hypertension	0.000376	0.0168	CbGeAlD
Naratriptan—Eletriptan—HTR1B—hypertension	0.000368	0.129	CrCbGaD
Naratriptan—MAOA—cardiac atrium—hypertension	0.000366	0.0164	CbGeAlD
Naratriptan—HTR1A—adrenal gland—hypertension	0.00035	0.0157	CbGeAlD
Naratriptan—MAOA—medulla oblongata—hypertension	0.000345	0.0155	CbGeAlD
Naratriptan—HTR1B—central nervous system—hypertension	0.000339	0.0152	CbGeAlD
Naratriptan—HTR1D—central nervous system—hypertension	0.000328	0.0147	CbGeAlD
Naratriptan—MAOA—adrenal gland—hypertension	0.000319	0.0143	CbGeAlD
Naratriptan—Sumatriptan—DRD2—hypertension	0.000305	0.107	CrCbGaD
Naratriptan—HTR1A—endocrine gland—hypertension	0.000303	0.0136	CbGeAlD
Naratriptan—MAOA—endocrine gland—hypertension	0.000277	0.0124	CbGeAlD
Naratriptan—HTR1A—central nervous system—hypertension	0.000273	0.0122	CbGeAlD
Naratriptan—Eletriptan—PTGS1—hypertension	0.000257	0.09	CrCbGaD
Naratriptan—MAOA—central nervous system—hypertension	0.00025	0.0112	CbGeAlD
Naratriptan—Rash—Fosinopril—hypertension	2.35e-05	0.000113	CcSEcCtD
Naratriptan—Dermatitis—Fosinopril—hypertension	2.35e-05	0.000113	CcSEcCtD
Naratriptan—Vomiting—Nifedipine—hypertension	2.34e-05	0.000113	CcSEcCtD
Naratriptan—Rash—Eplerenone—hypertension	2.34e-05	0.000112	CcSEcCtD
Naratriptan—Urticaria—Perindopril—hypertension	2.34e-05	0.000112	CcSEcCtD
Naratriptan—Headache—Fosinopril—hypertension	2.34e-05	0.000112	CcSEcCtD
Naratriptan—Hypersensitivity—Trandolapril—hypertension	2.34e-05	0.000112	CcSEcCtD
Naratriptan—Dermatitis—Eplerenone—hypertension	2.33e-05	0.000112	CcSEcCtD
Naratriptan—Diarrhoea—Valsartan—hypertension	2.33e-05	0.000112	CcSEcCtD
Naratriptan—Asthenia—Clonidine—hypertension	2.33e-05	0.000112	CcSEcCtD
Naratriptan—Feeling abnormal—Betaxolol—hypertension	2.33e-05	0.000112	CcSEcCtD
Naratriptan—Confusional state—Timolol—hypertension	2.33e-05	0.000112	CcSEcCtD
Naratriptan—Vomiting—Verapamil—hypertension	2.33e-05	0.000112	CcSEcCtD
Naratriptan—Urticaria—Irbesartan—hypertension	2.33e-05	0.000112	CcSEcCtD
Naratriptan—Shock—Ramipril—hypertension	2.33e-05	0.000112	CcSEcCtD
Naratriptan—Hypersensitivity—Enalapril—hypertension	2.33e-05	0.000112	CcSEcCtD
Naratriptan—Body temperature increased—Perindopril—hypertension	2.32e-05	0.000112	CcSEcCtD
Naratriptan—Palpitations—Lisinopril—hypertension	2.32e-05	0.000112	CcSEcCtD
Naratriptan—Diarrhoea—Olmesartan—hypertension	2.32e-05	0.000112	CcSEcCtD
Naratriptan—Headache—Eplerenone—hypertension	2.32e-05	0.000112	CcSEcCtD
Naratriptan—Rash—Nifedipine—hypertension	2.32e-05	0.000112	CcSEcCtD
Naratriptan—Nervous system disorder—Ramipril—hypertension	2.32e-05	0.000112	CcSEcCtD
Naratriptan—Dermatitis—Nifedipine—hypertension	2.32e-05	0.000112	CcSEcCtD
Naratriptan—Body temperature increased—Irbesartan—hypertension	2.32e-05	0.000112	CcSEcCtD
Naratriptan—Thrombocytopenia—Ramipril—hypertension	2.32e-05	0.000111	CcSEcCtD
Naratriptan—Anaphylactic shock—Timolol—hypertension	2.31e-05	0.000111	CcSEcCtD
Naratriptan—Oedema—Timolol—hypertension	2.31e-05	0.000111	CcSEcCtD
Naratriptan—Loss of consciousness—Lisinopril—hypertension	2.31e-05	0.000111	CcSEcCtD
Naratriptan—Rash—Verapamil—hypertension	2.31e-05	0.000111	CcSEcCtD
Naratriptan—Urticaria—Hydrochlorothiazide—hypertension	2.31e-05	0.000111	CcSEcCtD
Naratriptan—Dermatitis—Verapamil—hypertension	2.31e-05	0.000111	CcSEcCtD
Naratriptan—Headache—Nifedipine—hypertension	2.3e-05	0.000111	CcSEcCtD
Naratriptan—Pruritus—Clonidine—hypertension	2.3e-05	0.000111	CcSEcCtD
Naratriptan—Body temperature increased—Hydrochlorothiazide—hypertension	2.3e-05	0.000111	CcSEcCtD
Naratriptan—Skin disorder—Ramipril—hypertension	2.3e-05	0.000111	CcSEcCtD
Naratriptan—Infection—Timolol—hypertension	2.3e-05	0.000111	CcSEcCtD
Naratriptan—Headache—Verapamil—hypertension	2.29e-05	0.00011	CcSEcCtD
Naratriptan—Hypersensitivity—Telmisartan—hypertension	2.29e-05	0.00011	CcSEcCtD
Naratriptan—Cough—Lisinopril—hypertension	2.29e-05	0.00011	CcSEcCtD
Naratriptan—Nausea—Diltiazem—hypertension	2.29e-05	0.00011	CcSEcCtD
Naratriptan—Nausea—Indapamide—hypertension	2.29e-05	0.00011	CcSEcCtD
Naratriptan—Hyperhidrosis—Ramipril—hypertension	2.29e-05	0.00011	CcSEcCtD
Naratriptan—Asthenia—Trandolapril—hypertension	2.27e-05	0.000109	CcSEcCtD
Naratriptan—Shock—Timolol—hypertension	2.27e-05	0.000109	CcSEcCtD
Naratriptan—Feeling abnormal—Losartan—hypertension	2.27e-05	0.000109	CcSEcCtD
Naratriptan—Urticaria—Furosemide—hypertension	2.27e-05	0.000109	CcSEcCtD
Naratriptan—Nervous system disorder—Timolol—hypertension	2.27e-05	0.000109	CcSEcCtD
Naratriptan—Nausea—Carvedilol—hypertension	2.27e-05	0.000109	CcSEcCtD
Naratriptan—Asthenia—Enalapril—hypertension	2.27e-05	0.000109	CcSEcCtD
Naratriptan—Body temperature increased—Furosemide—hypertension	2.26e-05	0.000109	CcSEcCtD
Naratriptan—Dizziness—Valsartan—hypertension	2.25e-05	0.000109	CcSEcCtD
Naratriptan—Urticaria—Betaxolol—hypertension	2.25e-05	0.000108	CcSEcCtD
Naratriptan—Skin disorder—Timolol—hypertension	2.25e-05	0.000108	CcSEcCtD
Naratriptan—Dizziness—Olmesartan—hypertension	2.24e-05	0.000108	CcSEcCtD
Naratriptan—Pruritus—Trandolapril—hypertension	2.24e-05	0.000108	CcSEcCtD
Naratriptan—Nausea—Doxazosin—hypertension	2.24e-05	0.000108	CcSEcCtD
Naratriptan—Arthralgia—Lisinopril—hypertension	2.24e-05	0.000108	CcSEcCtD
Naratriptan—Myalgia—Lisinopril—hypertension	2.24e-05	0.000108	CcSEcCtD
Naratriptan—Body temperature increased—Betaxolol—hypertension	2.24e-05	0.000108	CcSEcCtD
Naratriptan—Hyperhidrosis—Timolol—hypertension	2.23e-05	0.000108	CcSEcCtD
Naratriptan—Asthenia—Telmisartan—hypertension	2.23e-05	0.000108	CcSEcCtD
Naratriptan—Pruritus—Enalapril—hypertension	2.23e-05	0.000108	CcSEcCtD
Naratriptan—Anxiety—Lisinopril—hypertension	2.23e-05	0.000107	CcSEcCtD
Naratriptan—Diarrhoea—Clonidine—hypertension	2.22e-05	0.000107	CcSEcCtD
Naratriptan—Nausea—Fosinopril—hypertension	2.21e-05	0.000107	CcSEcCtD
Naratriptan—Discomfort—Lisinopril—hypertension	2.21e-05	0.000106	CcSEcCtD
Naratriptan—Hypotension—Ramipril—hypertension	2.21e-05	0.000106	CcSEcCtD
Naratriptan—Pruritus—Telmisartan—hypertension	2.2e-05	0.000106	CcSEcCtD
Naratriptan—Nausea—Eplerenone—hypertension	2.2e-05	0.000106	CcSEcCtD
Naratriptan—Urticaria—Losartan—hypertension	2.19e-05	0.000105	CcSEcCtD
Naratriptan—Dry mouth—Lisinopril—hypertension	2.19e-05	0.000105	CcSEcCtD
Naratriptan—Nausea—Nifedipine—hypertension	2.18e-05	0.000105	CcSEcCtD
Naratriptan—Body temperature increased—Losartan—hypertension	2.18e-05	0.000105	CcSEcCtD
Naratriptan—Nausea—Verapamil—hypertension	2.18e-05	0.000105	CcSEcCtD
Naratriptan—Asthenia—Captopril—hypertension	2.17e-05	0.000105	CcSEcCtD
Naratriptan—Diarrhoea—Trandolapril—hypertension	2.17e-05	0.000104	CcSEcCtD
Naratriptan—Vomiting—Valsartan—hypertension	2.17e-05	0.000104	CcSEcCtD
Naratriptan—Confusional state—Lisinopril—hypertension	2.16e-05	0.000104	CcSEcCtD
Naratriptan—Diarrhoea—Enalapril—hypertension	2.16e-05	0.000104	CcSEcCtD
Naratriptan—Hypotension—Timolol—hypertension	2.16e-05	0.000104	CcSEcCtD
Naratriptan—Hypersensitivity—Irbesartan—hypertension	2.16e-05	0.000104	CcSEcCtD
Naratriptan—Vomiting—Olmesartan—hypertension	2.16e-05	0.000104	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Ramipril—hypertension	2.15e-05	0.000104	CcSEcCtD
Naratriptan—Rash—Valsartan—hypertension	2.15e-05	0.000103	CcSEcCtD
Naratriptan—Dizziness—Clonidine—hypertension	2.15e-05	0.000103	CcSEcCtD
Naratriptan—Dermatitis—Valsartan—hypertension	2.15e-05	0.000103	CcSEcCtD
Naratriptan—Oedema—Lisinopril—hypertension	2.14e-05	0.000103	CcSEcCtD
Naratriptan—Anaphylactic shock—Lisinopril—hypertension	2.14e-05	0.000103	CcSEcCtD
Naratriptan—Pruritus—Captopril—hypertension	2.14e-05	0.000103	CcSEcCtD
Naratriptan—Hypersensitivity—Hydrochlorothiazide—hypertension	2.14e-05	0.000103	CcSEcCtD
Naratriptan—Rash—Olmesartan—hypertension	2.14e-05	0.000103	CcSEcCtD
Naratriptan—Dermatitis—Olmesartan—hypertension	2.14e-05	0.000103	CcSEcCtD
Naratriptan—Headache—Valsartan—hypertension	2.14e-05	0.000103	CcSEcCtD
Naratriptan—Diarrhoea—Telmisartan—hypertension	2.13e-05	0.000103	CcSEcCtD
Naratriptan—Infection—Lisinopril—hypertension	2.13e-05	0.000103	CcSEcCtD
Naratriptan—Headache—Olmesartan—hypertension	2.13e-05	0.000102	CcSEcCtD
Naratriptan—Paraesthesia—Ramipril—hypertension	2.12e-05	0.000102	CcSEcCtD
Naratriptan—Shock—Lisinopril—hypertension	2.11e-05	0.000102	CcSEcCtD
Naratriptan—Asthenia—Perindopril—hypertension	2.11e-05	0.000102	CcSEcCtD
Naratriptan—Dyspnoea—Ramipril—hypertension	2.11e-05	0.000101	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Timolol—hypertension	2.11e-05	0.000101	CcSEcCtD
Naratriptan—Hypersensitivity—Furosemide—hypertension	2.11e-05	0.000101	CcSEcCtD
Naratriptan—Asthenia—Irbesartan—hypertension	2.1e-05	0.000101	CcSEcCtD
Naratriptan—Somnolence—Ramipril—hypertension	2.1e-05	0.000101	CcSEcCtD
Naratriptan—Thrombocytopenia—Lisinopril—hypertension	2.1e-05	0.000101	CcSEcCtD
Naratriptan—Dizziness—Trandolapril—hypertension	2.1e-05	0.000101	CcSEcCtD
Naratriptan—Dizziness—Enalapril—hypertension	2.09e-05	0.0001	CcSEcCtD
Naratriptan—Asthenia—Hydrochlorothiazide—hypertension	2.09e-05	0.0001	CcSEcCtD
Naratriptan—Hypersensitivity—Betaxolol—hypertension	2.08e-05	0.0001	CcSEcCtD
Naratriptan—Skin disorder—Lisinopril—hypertension	2.08e-05	0.0001	CcSEcCtD
Naratriptan—Pruritus—Perindopril—hypertension	2.08e-05	0.0001	CcSEcCtD
Naratriptan—Paraesthesia—Timolol—hypertension	2.08e-05	9.99e-05	CcSEcCtD
Naratriptan—Pruritus—Irbesartan—hypertension	2.07e-05	9.98e-05	CcSEcCtD
Naratriptan—Hyperhidrosis—Lisinopril—hypertension	2.07e-05	9.98e-05	CcSEcCtD
Naratriptan—Diarrhoea—Captopril—hypertension	2.07e-05	9.97e-05	CcSEcCtD
Naratriptan—Vomiting—Clonidine—hypertension	2.07e-05	9.95e-05	CcSEcCtD
Naratriptan—Dyspnoea—Timolol—hypertension	2.06e-05	9.92e-05	CcSEcCtD
Naratriptan—Dizziness—Telmisartan—hypertension	2.06e-05	9.91e-05	CcSEcCtD
Naratriptan—Pruritus—Hydrochlorothiazide—hypertension	2.06e-05	9.9e-05	CcSEcCtD
Naratriptan—Somnolence—Timolol—hypertension	2.05e-05	9.89e-05	CcSEcCtD
Naratriptan—Asthenia—Furosemide—hypertension	2.05e-05	9.87e-05	CcSEcCtD
Naratriptan—Rash—Clonidine—hypertension	2.05e-05	9.86e-05	CcSEcCtD
Naratriptan—Dermatitis—Clonidine—hypertension	2.05e-05	9.86e-05	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Ramipril—hypertension	2.04e-05	9.83e-05	CcSEcCtD
Naratriptan—Fatigue—Ramipril—hypertension	2.04e-05	9.81e-05	CcSEcCtD
Naratriptan—Headache—Clonidine—hypertension	2.04e-05	9.8e-05	CcSEcCtD
Naratriptan—Hypersensitivity—Losartan—hypertension	2.03e-05	9.78e-05	CcSEcCtD
Naratriptan—Asthenia—Betaxolol—hypertension	2.03e-05	9.77e-05	CcSEcCtD
Naratriptan—Nausea—Valsartan—hypertension	2.03e-05	9.75e-05	CcSEcCtD
Naratriptan—Pruritus—Furosemide—hypertension	2.02e-05	9.73e-05	CcSEcCtD
Naratriptan—Constipation—Ramipril—hypertension	2.02e-05	9.73e-05	CcSEcCtD
Naratriptan—Nausea—Olmesartan—hypertension	2.02e-05	9.7e-05	CcSEcCtD
Naratriptan—Vomiting—Trandolapril—hypertension	2.02e-05	9.7e-05	CcSEcCtD
Naratriptan—Diarrhoea—Perindopril—hypertension	2.01e-05	9.68e-05	CcSEcCtD
Naratriptan—Vomiting—Enalapril—hypertension	2.01e-05	9.66e-05	CcSEcCtD
Naratriptan—Diarrhoea—Irbesartan—hypertension	2e-05	9.65e-05	CcSEcCtD
Naratriptan—Hypotension—Lisinopril—hypertension	2e-05	9.65e-05	CcSEcCtD
Naratriptan—Dizziness—Captopril—hypertension	2e-05	9.64e-05	CcSEcCtD
Naratriptan—Pruritus—Betaxolol—hypertension	2e-05	9.64e-05	CcSEcCtD
Naratriptan—Rash—Trandolapril—hypertension	2e-05	9.62e-05	CcSEcCtD
Naratriptan—Dermatitis—Trandolapril—hypertension	2e-05	9.61e-05	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Timolol—hypertension	2e-05	9.61e-05	CcSEcCtD
Naratriptan—Fatigue—Timolol—hypertension	1.99e-05	9.59e-05	CcSEcCtD
Naratriptan—Rash—Enalapril—hypertension	1.99e-05	9.58e-05	CcSEcCtD
Naratriptan—Dermatitis—Enalapril—hypertension	1.99e-05	9.57e-05	CcSEcCtD
Naratriptan—Diarrhoea—Hydrochlorothiazide—hypertension	1.99e-05	9.57e-05	CcSEcCtD
Naratriptan—Headache—Trandolapril—hypertension	1.99e-05	9.56e-05	CcSEcCtD
Naratriptan—Vomiting—Telmisartan—hypertension	1.98e-05	9.53e-05	CcSEcCtD
Naratriptan—Asthenia—Losartan—hypertension	1.98e-05	9.52e-05	CcSEcCtD
Naratriptan—Headache—Enalapril—hypertension	1.98e-05	9.52e-05	CcSEcCtD
Naratriptan—Pain—Timolol—hypertension	1.98e-05	9.52e-05	CcSEcCtD
Naratriptan—Rash—Telmisartan—hypertension	1.96e-05	9.45e-05	CcSEcCtD
Naratriptan—Dermatitis—Telmisartan—hypertension	1.96e-05	9.44e-05	CcSEcCtD
Naratriptan—Diarrhoea—Furosemide—hypertension	1.96e-05	9.41e-05	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Lisinopril—hypertension	1.95e-05	9.4e-05	CcSEcCtD
Naratriptan—Pruritus—Losartan—hypertension	1.95e-05	9.39e-05	CcSEcCtD
Naratriptan—Headache—Telmisartan—hypertension	1.95e-05	9.39e-05	CcSEcCtD
Naratriptan—Feeling abnormal—Ramipril—hypertension	1.95e-05	9.38e-05	CcSEcCtD
Naratriptan—Dizziness—Perindopril—hypertension	1.94e-05	9.36e-05	CcSEcCtD
Naratriptan—Dizziness—Irbesartan—hypertension	1.94e-05	9.33e-05	CcSEcCtD
Naratriptan—Diarrhoea—Betaxolol—hypertension	1.94e-05	9.32e-05	CcSEcCtD
Naratriptan—Nausea—Clonidine—hypertension	1.93e-05	9.29e-05	CcSEcCtD
Naratriptan—Paraesthesia—Lisinopril—hypertension	1.93e-05	9.27e-05	CcSEcCtD
Naratriptan—Vomiting—Captopril—hypertension	1.93e-05	9.27e-05	CcSEcCtD
Naratriptan—Dizziness—Hydrochlorothiazide—hypertension	1.92e-05	9.25e-05	CcSEcCtD
Naratriptan—Dyspnoea—Lisinopril—hypertension	1.91e-05	9.2e-05	CcSEcCtD
Naratriptan—Rash—Captopril—hypertension	1.91e-05	9.19e-05	CcSEcCtD
Naratriptan—Dermatitis—Captopril—hypertension	1.91e-05	9.18e-05	CcSEcCtD
Naratriptan—Somnolence—Lisinopril—hypertension	1.91e-05	9.18e-05	CcSEcCtD
Naratriptan—Feeling abnormal—Timolol—hypertension	1.9e-05	9.17e-05	CcSEcCtD
Naratriptan—Headache—Captopril—hypertension	1.9e-05	9.13e-05	CcSEcCtD
Naratriptan—Dizziness—Furosemide—hypertension	1.89e-05	9.1e-05	CcSEcCtD
Naratriptan—Diarrhoea—Losartan—hypertension	1.89e-05	9.08e-05	CcSEcCtD
Naratriptan—Nausea—Trandolapril—hypertension	1.88e-05	9.06e-05	CcSEcCtD
Naratriptan—Urticaria—Ramipril—hypertension	1.88e-05	9.04e-05	CcSEcCtD
Naratriptan—Nausea—Enalapril—hypertension	1.88e-05	9.03e-05	CcSEcCtD
Naratriptan—Dizziness—Betaxolol—hypertension	1.87e-05	9.01e-05	CcSEcCtD
Naratriptan—Vomiting—Perindopril—hypertension	1.87e-05	9e-05	CcSEcCtD
Naratriptan—Body temperature increased—Ramipril—hypertension	1.87e-05	9e-05	CcSEcCtD
Naratriptan—Vomiting—Irbesartan—hypertension	1.86e-05	8.97e-05	CcSEcCtD
Naratriptan—Rash—Perindopril—hypertension	1.85e-05	8.92e-05	CcSEcCtD
Naratriptan—Dermatitis—Perindopril—hypertension	1.85e-05	8.91e-05	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Lisinopril—hypertension	1.85e-05	8.91e-05	CcSEcCtD
Naratriptan—Nausea—Telmisartan—hypertension	1.85e-05	8.9e-05	CcSEcCtD
Naratriptan—Fatigue—Lisinopril—hypertension	1.85e-05	8.9e-05	CcSEcCtD
Naratriptan—Vomiting—Hydrochlorothiazide—hypertension	1.85e-05	8.89e-05	CcSEcCtD
Naratriptan—Rash—Irbesartan—hypertension	1.85e-05	8.89e-05	CcSEcCtD
Naratriptan—Dermatitis—Irbesartan—hypertension	1.85e-05	8.89e-05	CcSEcCtD
Naratriptan—Headache—Perindopril—hypertension	1.84e-05	8.87e-05	CcSEcCtD
Naratriptan—Urticaria—Timolol—hypertension	1.84e-05	8.84e-05	CcSEcCtD
Naratriptan—Headache—Irbesartan—hypertension	1.84e-05	8.84e-05	CcSEcCtD
Naratriptan—Pain—Lisinopril—hypertension	1.83e-05	8.83e-05	CcSEcCtD
Naratriptan—Constipation—Lisinopril—hypertension	1.83e-05	8.83e-05	CcSEcCtD
Naratriptan—Rash—Hydrochlorothiazide—hypertension	1.83e-05	8.82e-05	CcSEcCtD
Naratriptan—Dermatitis—Hydrochlorothiazide—hypertension	1.83e-05	8.81e-05	CcSEcCtD
Naratriptan—Body temperature increased—Timolol—hypertension	1.83e-05	8.8e-05	CcSEcCtD
Naratriptan—Dizziness—Losartan—hypertension	1.82e-05	8.78e-05	CcSEcCtD
Naratriptan—Headache—Hydrochlorothiazide—hypertension	1.82e-05	8.76e-05	CcSEcCtD
Naratriptan—Vomiting—Furosemide—hypertension	1.82e-05	8.75e-05	CcSEcCtD
Naratriptan—Rash—Furosemide—hypertension	1.8e-05	8.67e-05	CcSEcCtD
Naratriptan—Dermatitis—Furosemide—hypertension	1.8e-05	8.67e-05	CcSEcCtD
Naratriptan—Vomiting—Betaxolol—hypertension	1.8e-05	8.66e-05	CcSEcCtD
Naratriptan—Nausea—Captopril—hypertension	1.8e-05	8.66e-05	CcSEcCtD
Naratriptan—Headache—Furosemide—hypertension	1.79e-05	8.62e-05	CcSEcCtD
Naratriptan—Rash—Betaxolol—hypertension	1.78e-05	8.59e-05	CcSEcCtD
Naratriptan—Dermatitis—Betaxolol—hypertension	1.78e-05	8.58e-05	CcSEcCtD
Naratriptan—Headache—Betaxolol—hypertension	1.77e-05	8.53e-05	CcSEcCtD
Naratriptan—Feeling abnormal—Lisinopril—hypertension	1.77e-05	8.51e-05	CcSEcCtD
Naratriptan—Vomiting—Losartan—hypertension	1.75e-05	8.44e-05	CcSEcCtD
Naratriptan—Nausea—Perindopril—hypertension	1.75e-05	8.41e-05	CcSEcCtD
Naratriptan—Hypersensitivity—Ramipril—hypertension	1.74e-05	8.39e-05	CcSEcCtD
Naratriptan—Nausea—Irbesartan—hypertension	1.74e-05	8.38e-05	CcSEcCtD
Naratriptan—Rash—Losartan—hypertension	1.74e-05	8.37e-05	CcSEcCtD
Naratriptan—Dermatitis—Losartan—hypertension	1.74e-05	8.36e-05	CcSEcCtD
Naratriptan—Headache—Losartan—hypertension	1.73e-05	8.32e-05	CcSEcCtD
Naratriptan—Nausea—Hydrochlorothiazide—hypertension	1.73e-05	8.31e-05	CcSEcCtD
Naratriptan—Urticaria—Lisinopril—hypertension	1.7e-05	8.2e-05	CcSEcCtD
Naratriptan—Hypersensitivity—Timolol—hypertension	1.7e-05	8.2e-05	CcSEcCtD
Naratriptan—Nausea—Furosemide—hypertension	1.7e-05	8.17e-05	CcSEcCtD
Naratriptan—Asthenia—Ramipril—hypertension	1.7e-05	8.17e-05	CcSEcCtD
Naratriptan—Body temperature increased—Lisinopril—hypertension	1.7e-05	8.16e-05	CcSEcCtD
Naratriptan—Nausea—Betaxolol—hypertension	1.68e-05	8.09e-05	CcSEcCtD
Naratriptan—Pruritus—Ramipril—hypertension	1.67e-05	8.05e-05	CcSEcCtD
Naratriptan—Asthenia—Timolol—hypertension	1.66e-05	7.98e-05	CcSEcCtD
Naratriptan—Nausea—Losartan—hypertension	1.64e-05	7.88e-05	CcSEcCtD
Naratriptan—Pruritus—Timolol—hypertension	1.64e-05	7.87e-05	CcSEcCtD
Naratriptan—Diarrhoea—Ramipril—hypertension	1.62e-05	7.79e-05	CcSEcCtD
Naratriptan—Diarrhoea—Timolol—hypertension	1.58e-05	7.61e-05	CcSEcCtD
Naratriptan—Hypersensitivity—Lisinopril—hypertension	1.58e-05	7.61e-05	CcSEcCtD
Naratriptan—Dizziness—Ramipril—hypertension	1.56e-05	7.53e-05	CcSEcCtD
Naratriptan—Asthenia—Lisinopril—hypertension	1.54e-05	7.41e-05	CcSEcCtD
Naratriptan—Dizziness—Timolol—hypertension	1.53e-05	7.36e-05	CcSEcCtD
Naratriptan—Pruritus—Lisinopril—hypertension	1.52e-05	7.3e-05	CcSEcCtD
Naratriptan—Vomiting—Ramipril—hypertension	1.5e-05	7.24e-05	CcSEcCtD
Naratriptan—Rash—Ramipril—hypertension	1.49e-05	7.18e-05	CcSEcCtD
Naratriptan—Dermatitis—Ramipril—hypertension	1.49e-05	7.17e-05	CcSEcCtD
Naratriptan—Headache—Ramipril—hypertension	1.48e-05	7.13e-05	CcSEcCtD
Naratriptan—Vomiting—Timolol—hypertension	1.47e-05	7.07e-05	CcSEcCtD
Naratriptan—Diarrhoea—Lisinopril—hypertension	1.47e-05	7.06e-05	CcSEcCtD
Naratriptan—Rash—Timolol—hypertension	1.46e-05	7.02e-05	CcSEcCtD
Naratriptan—Dermatitis—Timolol—hypertension	1.46e-05	7.01e-05	CcSEcCtD
Naratriptan—Headache—Timolol—hypertension	1.45e-05	6.97e-05	CcSEcCtD
Naratriptan—Dizziness—Lisinopril—hypertension	1.42e-05	6.83e-05	CcSEcCtD
Naratriptan—Nausea—Ramipril—hypertension	1.4e-05	6.76e-05	CcSEcCtD
Naratriptan—Nausea—Timolol—hypertension	1.37e-05	6.61e-05	CcSEcCtD
Naratriptan—Vomiting—Lisinopril—hypertension	1.36e-05	6.56e-05	CcSEcCtD
Naratriptan—Rash—Lisinopril—hypertension	1.35e-05	6.51e-05	CcSEcCtD
Naratriptan—Dermatitis—Lisinopril—hypertension	1.35e-05	6.5e-05	CcSEcCtD
Naratriptan—Headache—Lisinopril—hypertension	1.34e-05	6.47e-05	CcSEcCtD
Naratriptan—Nausea—Lisinopril—hypertension	1.27e-05	6.13e-05	CcSEcCtD
Naratriptan—HTR1F—Signaling Pathways—NOS3—hypertension	5.03e-06	4.47e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LPL—hypertension	5.01e-06	4.46e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADCY5—hypertension	5.01e-06	4.46e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CALM2—hypertension	4.99e-06	4.44e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRKCG—hypertension	4.98e-06	4.43e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—H2AFX—hypertension	4.98e-06	4.43e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PDGFRB—hypertension	4.97e-06	4.42e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RPS6KB1—hypertension	4.97e-06	4.42e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ITGB3—hypertension	4.94e-06	4.4e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRKCA—hypertension	4.94e-06	4.4e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT2—hypertension	4.93e-06	4.38e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD2—hypertension	4.92e-06	4.37e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR7—hypertension	4.92e-06	4.37e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADCY5—hypertension	4.91e-06	4.37e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—YWHAZ—hypertension	4.9e-06	4.36e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRKCG—hypertension	4.87e-06	4.34e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GCG—hypertension	4.87e-06	4.33e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTPN1—hypertension	4.87e-06	4.33e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NGF—hypertension	4.85e-06	4.31e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SPP1—hypertension	4.85e-06	4.31e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ITGB3—hypertension	4.84e-06	4.31e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRKCA—hypertension	4.84e-06	4.31e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MTHFR—hypertension	4.84e-06	4.3e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCL8—hypertension	4.83e-06	4.3e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—YWHAZ—hypertension	4.8e-06	4.27e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KL—hypertension	4.77e-06	4.25e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH2—hypertension	4.77e-06	4.25e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NGF—hypertension	4.75e-06	4.22e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SPP1—hypertension	4.75e-06	4.22e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARA—hypertension	4.75e-06	4.22e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—RELA—hypertension	4.73e-06	4.21e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCL8—hypertension	4.73e-06	4.21e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCR5—hypertension	4.72e-06	4.2e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRKCD—hypertension	4.72e-06	4.2e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NGFR—hypertension	4.68e-06	4.17e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ITGAV—hypertension	4.68e-06	4.17e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KNG1—hypertension	4.67e-06	4.16e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—POMC—hypertension	4.65e-06	4.14e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRL—hypertension	4.64e-06	4.13e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AGTR1—hypertension	4.64e-06	4.13e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MTOR—hypertension	4.64e-06	4.13e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRKCD—hypertension	4.62e-06	4.11e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCR5—hypertension	4.62e-06	4.11e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2A—hypertension	4.62e-06	4.11e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—C3—hypertension	4.61e-06	4.1e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AGT—hypertension	4.6e-06	4.09e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HDAC1—hypertension	4.58e-06	4.07e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STK11—hypertension	4.58e-06	4.07e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL2—hypertension	4.55e-06	4.05e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL10—hypertension	4.54e-06	4.04e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PLG—hypertension	4.52e-06	4.03e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2A—hypertension	4.52e-06	4.02e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CALM1—hypertension	4.52e-06	4.02e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—RHOA—hypertension	4.52e-06	4.02e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—C3—hypertension	4.51e-06	4.02e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOE—hypertension	4.5e-06	4.01e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PDGFB—hypertension	4.49e-06	3.99e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT2—hypertension	4.47e-06	3.98e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3R1—hypertension	4.47e-06	3.98e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FGFR1—hypertension	4.46e-06	3.97e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CAV1—hypertension	4.46e-06	3.97e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCL8—hypertension	4.46e-06	3.97e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOA1—hypertension	4.45e-06	3.96e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADRB2—hypertension	4.4e-06	3.92e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HIF1A—hypertension	4.4e-06	3.91e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PDGFB—hypertension	4.39e-06	3.91e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AGT—hypertension	4.38e-06	3.9e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FGFR1—hypertension	4.37e-06	3.89e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCE—hypertension	4.35e-06	3.87e-05	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—AKT1—hypertension	4.31e-06	3.83e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CALM1—hypertension	4.31e-06	3.83e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HIF1A—hypertension	4.3e-06	3.83e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PDGFA—hypertension	4.29e-06	3.82e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VAV3—hypertension	4.29e-06	3.82e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOE—hypertension	4.29e-06	3.82e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LEP—hypertension	4.29e-06	3.82e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AGT—hypertension	4.29e-06	3.82e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CAV1—hypertension	4.25e-06	3.78e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOA1—hypertension	4.24e-06	3.77e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—hypertension	4.24e-06	3.77e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFBR2—hypertension	4.23e-06	3.77e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CALM1—hypertension	4.22e-06	3.75e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KDR—hypertension	4.2e-06	3.74e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LEP—hypertension	4.2e-06	3.74e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOE—hypertension	4.2e-06	3.74e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GNB3—hypertension	4.19e-06	3.73e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CAV1—hypertension	4.16e-06	3.7e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOA1—hypertension	4.15e-06	3.7e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AVP—hypertension	4.14e-06	3.68e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KDR—hypertension	4.12e-06	3.66e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—RHOA—hypertension	4.1e-06	3.65e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GNAS—hypertension	4.08e-06	3.63e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3R1—hypertension	4.06e-06	3.61e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—F2—hypertension	4.05e-06	3.6e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FN1—hypertension	4.05e-06	3.6e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRKCB—hypertension	4.05e-06	3.6e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MMP9—hypertension	4.03e-06	3.59e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CDKN1A—hypertension	4.02e-06	3.58e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTEN—hypertension	4.01e-06	3.57e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOB—hypertension	4e-06	3.56e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTK2—hypertension	3.98e-06	3.54e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCL8—hypertension	3.97e-06	3.53e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—F2—hypertension	3.96e-06	3.53e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRKCB—hypertension	3.96e-06	3.53e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FN1—hypertension	3.96e-06	3.53e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOTCH1—hypertension	3.96e-06	3.52e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EDN1—hypertension	3.94e-06	3.5e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK8—hypertension	3.92e-06	3.49e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARG—hypertension	3.92e-06	3.49e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—AKT1—hypertension	3.91e-06	3.48e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL5—hypertension	3.91e-06	3.48e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOTCH1—hypertension	3.88e-06	3.45e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—POMC—hypertension	3.87e-06	3.44e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—INS—hypertension	3.85e-06	3.42e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EP300—hypertension	3.82e-06	3.4e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LPL—hypertension	3.82e-06	3.4e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—H2AFX—hypertension	3.79e-06	3.37e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RPS6KB1—hypertension	3.78e-06	3.37e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PDGFRB—hypertension	3.78e-06	3.37e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADCY5—hypertension	3.74e-06	3.33e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SRC—hypertension	3.72e-06	3.31e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCG—hypertension	3.71e-06	3.3e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ITGB3—hypertension	3.69e-06	3.28e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCA—hypertension	3.69e-06	3.28e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—POMC—hypertension	3.69e-06	3.28e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—INS—hypertension	3.67e-06	3.26e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—YWHAZ—hypertension	3.66e-06	3.25e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—VEGFA—hypertension	3.62e-06	3.22e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SPP1—hypertension	3.62e-06	3.22e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NGF—hypertension	3.62e-06	3.22e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—POMC—hypertension	3.61e-06	3.21e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL2—hypertension	3.61e-06	3.21e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCL8—hypertension	3.6e-06	3.2e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—INS—hypertension	3.59e-06	3.19e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1—hypertension	3.55e-06	3.16e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT2—hypertension	3.54e-06	3.15e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL2—hypertension	3.53e-06	3.14e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—EGFR—hypertension	3.53e-06	3.14e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ALB—hypertension	3.53e-06	3.14e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCD—hypertension	3.52e-06	3.13e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR5—hypertension	3.52e-06	3.13e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1—hypertension	3.47e-06	3.09e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT2—hypertension	3.47e-06	3.09e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—EGFR—hypertension	3.46e-06	3.07e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2A—hypertension	3.44e-06	3.06e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—C3—hypertension	3.44e-06	3.06e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3R1—hypertension	3.37e-06	3e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NOS3—hypertension	3.37e-06	3e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SERPINE1—hypertension	3.37e-06	3e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PDGFB—hypertension	3.35e-06	2.98e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MYC—hypertension	3.33e-06	2.97e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGFR1—hypertension	3.33e-06	2.96e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TGFB1—hypertension	3.32e-06	2.96e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SERPINE1—hypertension	3.3e-06	2.93e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HIF1A—hypertension	3.28e-06	2.92e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AGT—hypertension	3.27e-06	2.91e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FGF2—hypertension	3.26e-06	2.9e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EGFR—hypertension	3.26e-06	2.9e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RHOA—hypertension	3.25e-06	2.89e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3R1—hypertension	3.22e-06	2.86e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOS3—hypertension	3.22e-06	2.86e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CALM1—hypertension	3.21e-06	2.86e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LEP—hypertension	3.2e-06	2.85e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOE—hypertension	3.2e-06	2.85e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FGF2—hypertension	3.19e-06	2.84e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RHOA—hypertension	3.18e-06	2.83e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CAV1—hypertension	3.17e-06	2.82e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOA1—hypertension	3.16e-06	2.82e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3R1—hypertension	3.15e-06	2.8e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOS3—hypertension	3.15e-06	2.8e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KDR—hypertension	3.14e-06	2.79e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—hypertension	3.09e-06	2.75e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RELA—hypertension	3.03e-06	2.69e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCB—hypertension	3.02e-06	2.69e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—F2—hypertension	3.02e-06	2.69e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FN1—hypertension	3.02e-06	2.69e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MTOR—hypertension	2.97e-06	2.64e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RELA—hypertension	2.96e-06	2.64e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH1—hypertension	2.95e-06	2.63e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MTOR—hypertension	2.91e-06	2.59e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL8—hypertension	2.85e-06	2.54e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL8—hypertension	2.79e-06	2.48e-05	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AKT1—hypertension	2.75e-06	2.45e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—POMC—hypertension	2.75e-06	2.45e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TP53—hypertension	2.74e-06	2.44e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—INS—hypertension	2.73e-06	2.43e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—hypertension	2.71e-06	2.41e-05	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AKT1—hypertension	2.7e-06	2.4e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTEN—hypertension	2.69e-06	2.39e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL2—hypertension	2.69e-06	2.39e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—hypertension	2.66e-06	2.36e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1—hypertension	2.65e-06	2.35e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT2—hypertension	2.64e-06	2.35e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—EGFR—hypertension	2.63e-06	2.34e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP9—hypertension	2.58e-06	2.3e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CDKN1A—hypertension	2.57e-06	2.29e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—EP300—hypertension	2.57e-06	2.28e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTEN—hypertension	2.56e-06	2.28e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP9—hypertension	2.53e-06	2.25e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CDKN1A—hypertension	2.52e-06	2.24e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SERPINE1—hypertension	2.51e-06	2.24e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTEN—hypertension	2.51e-06	2.23e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK8—hypertension	2.51e-06	2.23e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—hypertension	2.51e-06	2.23e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AKT1—hypertension	2.5e-06	2.23e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK8—hypertension	2.46e-06	2.19e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AKT1—hypertension	2.45e-06	2.18e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EP300—hypertension	2.45e-06	2.18e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGF2—hypertension	2.43e-06	2.16e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RHOA—hypertension	2.42e-06	2.16e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3R1—hypertension	2.4e-06	2.13e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOS3—hypertension	2.4e-06	2.13e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EP300—hypertension	2.39e-06	2.13e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SRC—hypertension	2.38e-06	2.12e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SRC—hypertension	2.33e-06	2.07e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—VEGFA—hypertension	2.32e-06	2.06e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT1—hypertension	2.31e-06	2.06e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—VEGFA—hypertension	2.27e-06	2.02e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RELA—hypertension	2.26e-06	2.01e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MTOR—hypertension	2.21e-06	1.97e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MYC—hypertension	2.13e-06	1.9e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL8—hypertension	2.13e-06	1.89e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFB1—hypertension	2.13e-06	1.89e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MYC—hypertension	2.09e-06	1.86e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGFR—hypertension	2.08e-06	1.85e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFB1—hypertension	2.08e-06	1.85e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT1—hypertension	2.05e-06	1.83e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGFR—hypertension	2.04e-06	1.82e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—hypertension	2.02e-06	1.8e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP9—hypertension	1.92e-06	1.71e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CDKN1A—hypertension	1.92e-06	1.71e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTEN—hypertension	1.91e-06	1.7e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK8—hypertension	1.87e-06	1.67e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT1—hypertension	1.87e-06	1.66e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EP300—hypertension	1.82e-06	1.62e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SRC—hypertension	1.77e-06	1.58e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TP53—hypertension	1.75e-06	1.56e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VEGFA—hypertension	1.73e-06	1.54e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TP53—hypertension	1.71e-06	1.52e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—hypertension	1.6e-06	1.43e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MYC—hypertension	1.59e-06	1.41e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFB1—hypertension	1.59e-06	1.41e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—hypertension	1.57e-06	1.4e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGFR—hypertension	1.55e-06	1.38e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AKT1—hypertension	1.55e-06	1.38e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT1—hypertension	1.48e-06	1.32e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT1—hypertension	1.45e-06	1.29e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TP53—hypertension	1.31e-06	1.16e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—hypertension	1.19e-06	1.06e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT1—hypertension	1.1e-06	9.81e-06	CbGpPWpGaD
